Novavax, Inc., a biopharmaceutical company, focuses on developing vaccines using its virus-like particle technology for infectious diseases. It develops vaccines for pandemic influenza, seasonal influenza, Varicella Zoster, and other disease targets. The company was founded in 1987 and is headquartered in Rockville, Maryland.

Sector & Industry Watch List